HT
INSY

HAP Trading’s Insys Therapeutics, Inc. INSY Stock Holding History

HAP Trading’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-53,500
Closed -$835K – 1245
2014
Q2 		$835K Sell
53,500
-6,560
-11% -$106K 0.03% 357
2014
Q1 		$1.24M Buy
+60,060
New +$1.19M 0.06% 288

Other funds holding INSY

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BTP
Bloom Tree Partners New York $215M AUM 17.45% 1-Year Est. Return

HAP Trading's INSY Position: Q3 2014 in Review

HAP Trading sold out of Insys Therapeutics, Inc. (INSY) in Q3 2014, closing a stake of 53,500 shares — an estimated $835K sold.

HAP Trading first reported a position in INSY in Q1 2014 and held it in 2 quarters. The position peaked at $1.24M in Q1 2014. 111 funds tracked by Wall St. Rank hold INSY as of Q3 2014.

  • HAP Trading reported no remaining Insys Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
  • HAP Trading sold 53,500 Insys Therapeutics, Inc. shares in Q3 2014, an estimated $835K.
  • HAP Trading first reported a position in Insys Therapeutics, Inc. in Q1 2014 and held it in 2 quarters.
  • HAP Trading's Insys Therapeutics, Inc. position peaked at $1.24M in Q1 2014.
  • 111 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2014.

Based on HAP Trading's 13F filing for Q3 2014, filed 10 Nov 2014.